TY - JOUR
T1 - Clinical guidelines of non-alcoholic fatty liver disease
T2 - A systematic review
AU - Zhu, Jin Zhou
AU - Hollis-Hansen, Kelseanna
AU - Wan, Xing Yong
AU - Fei, Su Juan
AU - Pang, Xun Lei
AU - Meng, Fan Dong
AU - Yu, Chao Hui
AU - Li, You Ming
N1 - Publisher Copyright:
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
PY - 2016/9/28
Y1 - 2016/9/28
N2 - AIM To perform a systematic review to grade guidelines and present recommendations for clinical management of non-alcoholic fatty liver disease (NAFLD). METHODS A database search was conducted on PubMed for guidelines published before May 2016, supplemented by reviewing relevant websites. The Appraisal of Guidelines for Research and Evaluation (ARGEE) instrument II was a tool designed to appraise the methodological rigor and transparency in which a clinical guideline is developed and it is used internationally. It was used to appraise the quality of guidelines in this study. The inclusion criteria include: clinical NAFLD guidelines for adults, published in English, and released by governmental agencies or key organizations. RESULTS Eleven guidelines were included in this study. Since 2007, guidelines have been released in Asia (3 in China, 1 in South Korea, and 1 in Japan), Europe (1 in Italy), America (1 in United States and 1 in Chile) and three international agencies [European associations joint, Asia-Pacific Working Party and World Gastroenterology Organization (WGO)]. Using the ARGEE II instrument, we found US 2012 and Europe 2016 had the highest scores, especially in the areas of rigor of development and applicability. Additionally, Italy 2010 and Korea 2013 also presented comprehensive content, rigorous procedures and good applicability. And WGO 2014 offered various algorithms for clinical practice. Lastly, a practical algorithm for the clinical management was developed, based on the recommended guidelines. CONCLUSION This is the first systematic review of NAFLD guidelines. It may yield insights for physicians and policy-makers in the development and application of guidelines.
AB - AIM To perform a systematic review to grade guidelines and present recommendations for clinical management of non-alcoholic fatty liver disease (NAFLD). METHODS A database search was conducted on PubMed for guidelines published before May 2016, supplemented by reviewing relevant websites. The Appraisal of Guidelines for Research and Evaluation (ARGEE) instrument II was a tool designed to appraise the methodological rigor and transparency in which a clinical guideline is developed and it is used internationally. It was used to appraise the quality of guidelines in this study. The inclusion criteria include: clinical NAFLD guidelines for adults, published in English, and released by governmental agencies or key organizations. RESULTS Eleven guidelines were included in this study. Since 2007, guidelines have been released in Asia (3 in China, 1 in South Korea, and 1 in Japan), Europe (1 in Italy), America (1 in United States and 1 in Chile) and three international agencies [European associations joint, Asia-Pacific Working Party and World Gastroenterology Organization (WGO)]. Using the ARGEE II instrument, we found US 2012 and Europe 2016 had the highest scores, especially in the areas of rigor of development and applicability. Additionally, Italy 2010 and Korea 2013 also presented comprehensive content, rigorous procedures and good applicability. And WGO 2014 offered various algorithms for clinical practice. Lastly, a practical algorithm for the clinical management was developed, based on the recommended guidelines. CONCLUSION This is the first systematic review of NAFLD guidelines. It may yield insights for physicians and policy-makers in the development and application of guidelines.
KW - Diagnosis
KW - Management
KW - Non-alcoholic fatty liver disease
KW - Systematic review
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=84991108002&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991108002&partnerID=8YFLogxK
U2 - 10.3748/wjg.v22.i36.8226
DO - 10.3748/wjg.v22.i36.8226
M3 - Review article
C2 - 27688665
AN - SCOPUS:84991108002
SN - 1007-9327
VL - 22
SP - 8226
EP - 8233
JO - World Journal of Gastroenterology
JF - World Journal of Gastroenterology
IS - 36
ER -